Effects of MAL‐PDT, ingenol mebutate and diclofenac plus hyaluronate gel monitored by high‐frequency ultrasound and digital dermoscopy in actinic keratosis – a randomized trial

The efficacy for actinic keratosis (AK) clearance of field‐directed treatments has been investigated in randomized studies against placebo, but the comparison of results is difficult for several methodological reasons.

[1]  P. Steijlen,et al.  Randomized Trial of Four Treatment Approaches for Actinic Keratosis , 2019, The New England journal of medicine.

[2]  Miri Kim,et al.  Anti‐aging effects of ingenol mebutate for patients with actinic keratosis , 2018, Journal of the American Academy of Dermatology.

[3]  P. Calzavara-Pinton,et al.  Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[4]  Michael R Hamblin,et al.  Remodeling of dermal collagen in photoaged skin using low‐dose 5‐aminolevulinic acid photodynamic therapy occurs via the transforming growth factor‐β pathway , 2018, Journal of biophotonics.

[5]  C. Morton.  A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin cancer. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[6]  T. Skov,et al.  Phase IV head‐to‐head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp , 2017, The British journal of dermatology.

[7]  Thomas Dirschka,et al.  Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology , 2017, The Journal of dermatological treatment.

[8]  J. Malvehy,et al.  A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  K. Peris,et al.  Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT , 2017, Journal of cutaneous medicine and surgery.

[10]  A. Offidani,et al.  Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  J. McGregor,et al.  British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017 , 2017, The British journal of dermatology.

[12]  G. Argenziano,et al.  Dermoscopy and in vivo confocal microscopy are complementary techniques for diagnosis of difficult amelanotic and light‐coloured skin lesions , 2016, The British journal of dermatology.

[13]  P. Calzavara-Pinton,et al.  Bucher’s indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis , 2016, European Journal of Dermatology.

[14]  P. Calzavara-Pinton,et al.  A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp , 2016, Dermatology.

[15]  K. Peris,et al.  Italian expert consensus for the management of actinic keratosis in immunocompetent patients , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  S. Shumack,et al.  Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  Dong Eun Kim,et al.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation , 2015, Nature Cell Biology.

[18]  A. Ariza,et al.  Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  B. Dréno,et al.  Management of actinic keratosis: a practical report and treatment algorithm from AKTeamTM expert clinicians , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  S. Vegter,et al.  A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe , 2014, PloS one.

[21]  P. Calzavara-Pinton,et al.  A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp , 2014, The British journal of dermatology.

[22]  H. S. de Bruijn,et al.  Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall. , 2013, Journal of Photochemistry and Photobiology. B: Biology.

[23]  S Schreml,et al.  Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy , 2012, The British journal of dermatology.

[24]  Harald Kittler,et al.  Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model. , 2012, Journal of the American Academy of Dermatology.

[25]  Arjen Amelink,et al.  Monitoring blood volume and saturation using superficial fibre optic reflectance spectroscopy during PDT of actinic keratosis , 2011, Journal of biophotonics.

[26]  Ulas Sunar,et al.  Monitoring blood flow responses during topical ALA-PDT , 2010, Biomedical optics express.

[27]  G. Jemec,et al.  In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20‐MHz ultrasound , 2009, The British journal of dermatology.

[28]  T. Hamilton,et al.  Molecular effects of photodynamic therapy for photoaging. , 2008, Archives of dermatology.

[29]  M. Venturini,et al.  Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin , 2007, Lasers in surgery and medicine.

[30]  H. Zhan,et al.  The Role of Topical Cyclo-Oxygenase-2 Inhibitors in Skin Cancer , 2007, American journal of clinical dermatology.

[31]  Hans Christian Wulf,et al.  Ultrasonographic subepidermal low‐echogenic band, dependence of age and body site , 2004, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[32]  R. M. Szeimiesa,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .

[33]  D. Salomon,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002, Journal of the American Academy of Dermatology.

[34]  J. Callen,et al.  A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. , 1991, Journal of the American Academy of Dermatology.